Lipvas 20 mg (Atorvastatin) cardiovascular risk reduction Use cautiously in women with

Use cautiously in women with ovarian cysts unrelated to infertility or pelvic masses

and absolute medical support through your healing journey

It is formulated specifically for the treatment of chronic hepatitis C virus (HCV) infection in adults

as growth‑promoting hormones may theoretically accelerate tumor progression

but do not double doses to compensate

Lipvas 20 mg (Atorvastatin) cardiovascular risk reduction Use cautiously in women withProduct Overview Lipvas 20 mg is a prescription tablet that contains 20 milligrams of Atorvastatin, a lipidlowering agent manufactured by Cipla Limited. The product is packaged in a strip containing ten tablets, making it suitable for a twoweek supply when taken as directed. It is indicated for patients with elevated lowdensity lipoprotein cholesterol (LDLC) and is commonly used as part of a comprehensive cardiovascular riskreduction strategy. What is